|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,860.00 KRW | +0.65% |
|
-18.65% | -43.90% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-03 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Quotes 5-day view: Genome & Company
End-of-day quote Korea S.E.| 24/06/2026 | 25/06/2026 | 26/06/2026 | 29/06/2026 | 30/06/2026 | |
|---|---|---|---|---|---|
| Last | ₩4,455.00 | ₩3,965.00 | ₩3,575.00 | ₩3,835.00 | ₩3,860.00 |
| Volume | 310,610 | 728,934 | 671,441 | 693,499 | 428,650 |
| Change | +2.89% | -11.00% | -9.84% | +7.27% | +0.65% |
| Opening | ₩4,330.00 | ₩4,455.00 | ₩3,900.00 | ₩3,520.00 | ₩3,835.00 |
| High | ₩4,590.00 | ₩4,545.00 | ₩3,950.00 | ₩3,975.00 | ₩4,100.00 |
| Low | ₩4,250.00 | ₩3,810.00 | ₩3,510.00 | ₩3,520.00 | ₩3,620.00 |
Performance
| 1 day | +0.65% | ||
| 1 week | -18.65% | ||
| Current month | -36.93% | ||
| 1 month | -36.93% | ||
| 3 months | -59.71% | ||
| 6 months | -44.86% | ||
| Current year | -43.90% | ||
| 1 year | +35.92% | ||
| 3 years | -54.27% | ||
| 5 years | -80.41% |
Volumes
marketsDaily volume
428,650
Avg. Volume 20 sessions
552,310
Avg. Volume 20 sessions KRW
2,131,916,600
Avg. Volume 20 sessions USD
1,379,350.04
Record volume 1
30,576,260
Record volume 2
14,495,024
Record volume 3
7,918,904
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (KRW)
173,918,577,167
Market Cap (USD)
112,306,247
Net sales ()
24,586,847,080
Net sales (USD)
15,876,720
Free-Float
82.63 %
Free-Float capitalization (KRW)
143,711,912,143
Free-Float capitalization (USD)
92,800,584
Average Daily Capital Traded
1.23%
Indicators
Moving average 5 days
3,938
Moving average 20 days
5,003.75
Moving average 50 days
5,912.1
Moving average 100 days
6,822.05
Price spread / (MMA5)
+2.02%
Price spread / (MMA20)
+29.63%
Price spread / (MMA50)
+53.16%
Price spread / (MMA100)
+76.74%
RSI 9 days
30.08
RSI 14 days
32.99
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.65% | -18.65% | +35.92% | -54.27% | 112M | |
| +1.15% | +9.07% | -3.67% | +4.36% | 46.62B | |
| -2.77% | +12.95% | +407.40% | +614.26% | 40.95B | |
| -0.03% | +15.14% | +22.70% | -12.74% | 32.26B | |
| -1.73% | +4.85% | +18.15% | +59.57% | 32.24B | |
| -3.29% | +2.85% | +13.80% | +30.30% | 25.53B | |
| +1.15% | +16.98% | - | - | 16.38B | |
| -0.96% | +16.22% | +70.46% | +125.41% | 15.27B | |
| +0.56% | +8.00% | +12.65% | +21.35% | 13.61B | |
| -1.74% | +4.48% | +99.22% | +92.87% | 13.34B | |
| Average | -0.70% | +7.96% | +75.18% | +97.90% | 23.63B | |
| Weighted average by Cap. | -0.90% | +10.35% | +94.38% | +141.31% |
Historical Quotes: Genome & Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 3,510 |  | 4,590 |
| 1 month | 3,510 | | 6,130 |
| Current year | 3,510 | | 10,180 |
| 1 year | 2,440 | | 10,180 |
| 3 years | 2,170 | | 10,180 |
| 5 years | 2,170 | | 28,800 |
| 10 years | 2,170 | | 47,500 |
Monthly variations
Annual variations
| 2026 | -43.90% | ||
| 2025 | +150.18% | ||
| 2024 | -55.96% | ||
| 2023 | -28.42% | ||
| 2022 | -49.71% | ||
| 2021 | -56.35% | ||
| 2020 | +102.29% | ||
| 2019 | +219.51% | ||
| 2018 | +31.83% |
- Stock Market
- Stocks
- A314130 Stock
- Quotes Genome & Company
Select your edition
All financial news and data tailored to specific country editions
